-
Panasas, HGST Offer iRODS Solution
Oct 7, 2016, 13:35 PM by Michael CroftBio-IT World Brief | Yesterday Panasas and HGST announced a solution using iRODS to link the Panasas ActiveStor storage system with HGST’s object storage Active Archive System.Full story -
Bill Gates Succumbs to Moonshot Madness
Oct 7, 2016, 10:52 AM by Michael CroftOmics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.Full story -
How to Get Relief from Chronic pain with Nerve Block Therapy?
Oct 6, 2016, 16:20 PM by Michael CroftWESTMINSTER, CA, UNITED STATES - Oct 7, 2016 - Chronic pain is a debilitating condition that is difficult to treat. Many people that suffer from chronic pain are not able to complete daily tasks to maintain their lifestyle simply because the pain is too greatFull story -
American Laboratory Trading (ALT) Selected into Agilent Technologies’ Channel Partnership Program
Oct 6, 2016, 12:10 PM by Michael CroftEAST LYME, CT, USA - Oct 6, 2016 - American Laboratory Trading Inc. (ALT), the largest provider of premium refurbished lab equipment in North America, has been selected by Agilent Technologies to be a part of its Channel Partnership ProgramFull story -
Biotech Billionaire Backs Company Geared At Ending Food Allergies
Oct 6, 2016, 11:04 AM by Michael CroftForbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.Full story -
Dramatic Twists Could Upend Patent Battle Over CRISPR Genome-Editing Method
Oct 6, 2016, 10:16 AM by Michael CroftScience | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.Full story -
Health Insurance Companies are Utilizing Cloud Computing to Improve Market Penetration Strategies
Oct 6, 2016, 07:34 AM by Michael CroftALBANY, NY, UNITED STATES - Oct 6, 2016 - The concept of health insurance, in general, is objectively simple whereinan individual or organization purchase services or plans to avoid their risk in event of un-avoidable health conditionsFull story -
IOMICS Announces Advanced Software to Identify Chemical Hazards
Oct 5, 2016, 13:57 PM by Michael CroftCAMBRIDGE, MA - Oct 5, 2016 - IOMICS today announced the release of its first vertical product, FUSION STS, a new class of chemical analytics that will allow scientists and chemical engineers to rapidly build and deploy in silico HTS systems that can be used stand-alone or to augment in vitro screening initiativesFull story -
Sekisui XenoTech Introduces Lysosomal Test Systems for Biopharmaceutical Development
Oct 5, 2016, 09:56 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Oct 5, 2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems. These products contain high concentrations of lysosomal degradative enzymes and constitute advantageous test systems for analysis of catabolism and/or activation for targeted biopharmaceuticals that enter cells through the endosomal-lysosomal pathwayFull story -
Rumors, Expectations Surround Apple Expansion Into Health Care
Oct 5, 2016, 09:15 AM by Michael CroftPOLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.Full story -
The International Biomedical Research Alliance Appoints Life Sciences Patent Lawyer to its Board
Oct 5, 2016, 08:38 AM by Michael CroftBETHESDA, MD - Oct 5, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Jeffrey IFull story -
Gene Editing Takes the Stage at Discovery on Target 2016
Oct 5, 2016, 07:00 AM by Michael CroftFull storyBio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.
-
Recipharm launches serialisation showcase line
Oct 5, 2016, 04:22 AM by Michael CroftFONTAINE, FRANCE - Oct 3, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has launched a showcase line for serialisation, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulationsFull story -
Azure is becoming the first AI supercomputer says Microsoft
Oct 4, 2016, 15:34 PM by Michael CroftZDNet | Microsoft's CEO on how its cloud computing service is evolving.Full story -
Anti-Aging Through Regenerative Medicine
Oct 4, 2016, 14:17 PM by Michael CroftCRYSTAL LAKE, IL, UNITED STATES - Oct 4, 2016 - Treatments utilizing regenerative medicine cause our bodys natural healing processes to work both more effectively and rapidlyFull story -
TARGET PharmaSolutions Announces the Launch of TARGET-PBC (Primary Biliary Cholangitis)
Oct 4, 2016, 12:43 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Oct 3, 2016 - TARGET PharmaSolutions, Inc. is pleased to announce the launch of TARGET-PBC (Primary Biliary Cholangitis)Full story -
Biotech PR Needs to Deliver More Signal Less Noise
Oct 4, 2016, 10:49 AM by Michael CroftForbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.Full story -
Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support
Oct 4, 2016, 10:14 AM by Michael CroftBASEL, N/A, SWITZERLAND - Oct 4, 2016 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14Full story -
STERLING PHARMA SOLUTIONS LAUNCHES FOLLOWING MANAGEMENT BUYOUT
Oct 4, 2016, 05:47 AM by Michael CroftDUDLEY, UK - Oct 3, 2016 - UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley siteFull story -
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Oct 3, 2016, 14:30 PM by Michael CroftFull storyBio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.